Atomistry » Bromine » PDB 4z91-5c9w » 5c0l
Atomistry »
  Bromine »
    PDB 4z91-5c9w »
      5c0l »

Bromine in PDB 5c0l: Fragment-Based Drug Discovery Targeting Inhibitor of Apoptosis Proteins: Compound 2

Protein crystallography data

The structure of Fragment-Based Drug Discovery Targeting Inhibitor of Apoptosis Proteins: Compound 2, PDB code: 5c0l was solved by G.Chessari, I.M.Buck, J.E.H.Day, P.J.Day, A.Iqbal, C.N.Johnson, E.J.Lewis, V.Martins, D.Miller, M.Reader, D.C.Rees, S.J.Rich, E.Tamanini, M.Vitorino, G.A.Ward, P.A.Williams, G.Williams, N.E.Wilsher, A.J.-A.Woolford, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 71.57 / 2.60
Space group P 41 2 2
Cell size a, b, c (Å), α, β, γ (°) 71.571, 71.571, 105.666, 90.00, 90.00, 90.00
R / Rfree (%) 20 / 23.2

Other elements in 5c0l:

The structure of Fragment-Based Drug Discovery Targeting Inhibitor of Apoptosis Proteins: Compound 2 also contains other interesting chemical elements:

Zinc (Zn) 1 atom

Bromine Binding Sites:

The binding sites of Bromine atom in the Fragment-Based Drug Discovery Targeting Inhibitor of Apoptosis Proteins: Compound 2 (pdb code 5c0l). This binding sites where shown within 5.0 Angstroms radius around Bromine atom.
In total only one binding site of Bromine was determined in the Fragment-Based Drug Discovery Targeting Inhibitor of Apoptosis Proteins: Compound 2, PDB code: 5c0l:

Bromine binding site 1 out of 1 in 5c0l

Go back to Bromine Binding Sites List in 5c0l
Bromine binding site 1 out of 1 in the Fragment-Based Drug Discovery Targeting Inhibitor of Apoptosis Proteins: Compound 2


Mono view


Stereo pair view

A full contact list of Bromine with other atoms in the Br binding site number 1 of Fragment-Based Drug Discovery Targeting Inhibitor of Apoptosis Proteins: Compound 2 within 5.0Å range:
probe atom residue distance (Å) B Occ
A:Br402

b:47.5
occ:0.77
BR1 A:4WJ402 0.0 47.5 0.8
C2 A:4WJ402 1.9 37.8 0.8
C6 A:4WJ402 2.8 33.3 0.8
C3 A:4WJ402 2.9 34.9 0.8
H14 A:4WJ402 3.1 33.4 0.8
H13 A:4WJ402 3.2 35.7 0.8
CE3 A:TRP323 3.7 31.3 1.0
OH A:TYR324 3.8 36.2 1.0
CD2 A:TRP323 4.0 31.3 1.0
N5 A:4WJ402 4.0 34.3 0.8
O A:GLY306 4.0 31.8 1.0
N4 A:4WJ402 4.0 34.3 0.8
CG A:TRP323 4.2 31.8 1.0
CZ3 A:TRP323 4.3 32.5 1.0
CB A:TRP323 4.4 30.8 1.0
CD2 A:LEU307 4.5 28.8 1.0
O A:HOH506 4.5 30.7 1.0
CZ A:TYR324 4.6 32.8 1.0
CE2 A:TRP323 4.7 33.2 1.0
CE1 A:TYR324 4.9 31.8 1.0

Reference:

G.Chessari, I.M.Buck, J.E.Day, P.J.Day, A.Iqbal, C.N.Johnson, E.J.Lewis, V.Martins, D.Miller, M.Reader, D.C.Rees, S.J.Rich, E.Tamanini, M.Vitorino, G.A.Ward, P.A.Williams, G.Williams, N.E.Wilsher, A.J.Woolford. Fragment-Based Drug Discovery Targeting Inhibitor of Apoptosis Proteins: Discovery of A Non-Alanine Lead Series with Dual Activity Against CIAP1 and Xiap. J.Med.Chem. V. 58 6574 2015.
ISSN: ISSN 0022-2623
PubMed: 26218264
DOI: 10.1021/ACS.JMEDCHEM.5B00706
Page generated: Mon Jul 7 08:02:58 2025

Last articles

Fe in 7M1K
Fe in 7M1J
Fe in 7M1I
Fe in 7M0H
Fe in 7M0F
Fe in 7LZO
Fe in 7LXD
Fe in 7LZN
Fe in 7LZK
Fe in 7LYX
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy